PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.92%
Net income growth under 50% of MCHP's 129.92%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.17%
Both reduce yoy D&A, with MCHP at -0.29%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-700.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
10.29%
SBC growth while MCHP is negative at -59.06%. John Neff would see competitor possibly controlling share issuance more tightly.
17.19%
Slight usage while MCHP is negative at -24.14%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-94.12%
Both yoy AR lines negative, with MCHP at -56.86%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-96.23%
Both reduce yoy inventory, with MCHP at -21.68%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
115.38%
AP growth well above MCHP's 77.68%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
38.49%
Some yoy usage while MCHP is negative at -50.46%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
131.25%
Some yoy increase while MCHP is negative at -15.52%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
15.35%
Some CFO growth while MCHP is negative at -0.82%. John Neff would note a short-term liquidity lead over the competitor.
-18.90%
Negative yoy CapEx while MCHP is 1.85%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-49.27%
Negative yoy purchasing while MCHP stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
12.95%
We have some liquidation growth while MCHP is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-561.29%
Both yoy lines negative, with MCHP at -7.28%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-103.00%
We reduce yoy invests while MCHP stands at 99.10%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-50.00%
We cut debt repayment yoy while MCHP is 63.90%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-47.83%
Negative yoy issuance while MCHP is 349.72%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-18.18%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.